Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease
Authors
Keywords
Phosphates, Hemoglobin, Iron deficiency anemia, Chronic kidney disease, Ferritin, Phase II clinical investigation, Adverse events, Iron deficiency
Journal
PLoS One
Volume 12, Issue 11, Pages e0188712
Publisher
Public Library of Science (PLoS)
Online
2017-11-30
DOI
10.1371/journal.pone.0188712
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nutritional Status in Adults with Predialysis Chronic Kidney Disease: KNOW-CKD Study
- (2017) Young Youl Hyun et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
- (2017) Steven Fishbane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease
- (2017) Jair Munoz Mendoza et al. KIDNEY INTERNATIONAL
- Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function
- (2016) K. L. Naylor et al. Clinical Journal of the American Society of Nephrology
- Phosphate Toxicity in CKD: The Killer among Us
- (2016) C. S. Ritter et al. Clinical Journal of the American Society of Nephrology
- CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders
- (2016) Xiuying Bai et al. JOURNAL OF CLINICAL INVESTIGATION
- How we diagnose and treat iron deficiency anemia
- (2015) Michael Auerbach et al. AMERICAN JOURNAL OF HEMATOLOGY
- A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
- (2015) Geoffrey A. Block et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A randomized trial of intravenous and oral iron in chronic kidney disease
- (2015) Rajiv Agarwal et al. KIDNEY INTERNATIONAL
- A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia
- (2015) Philip A. Kalra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD
- (2014) K. Yokoyama et al. Clinical Journal of the American Society of Nephrology
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis
- (2014) J. B. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
- (2014) I. C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Iron Nutrition and Premenopausal Women: Effects of Poor Iron Status on Physical and Neuropsychological Performance
- (2013) James P. McClung et al. Annual Review of Nutrition
- Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment
- (2012) Agneta A Pagels et al. Health and Quality of Life Outcomes
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Phosphate Binders in Moderate CKD
- (2012) G. A. Block et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Update on fibroblast growth factor 23 in chronic kidney disease
- (2012) Myles Wolf KIDNEY INTERNATIONAL
- Establishment of a simple test for iron absorption from the gastrointestinal tract
- (2011) Masayoshi Kobune et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
- (2010) Wajeh Y. Qunibi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Can the Response to Iron Therapy Be Predicted in Anemic Nondialysis Patients with Chronic Kidney Disease?
- (2009) S. Stancu et al. Clinical Journal of the American Society of Nephrology
- Iron Indices in Chronic Kidney Disease in the National Health and Nutritional Examination Survey 1988-2004
- (2008) S. Fishbane et al. Clinical Journal of the American Society of Nephrology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started